C5aR agonist enhances phagocytosis of fibrillar and non-fibrillar Aβ amyloid and preserves memory in a mouse model of familial Alzheimer’s disease-Reference-Cited by-同舟云学术

C5aR agonist enhances phagocytosis of fibrillar and non-fibrillar Aβ amyloid and preserves memory in a mouse model of familial Alzheimer’s disease

Published:2019-12-06 Issue:12 Volume:14 Page:e0225417
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Panayiotou Elena,Fella Eleni,Andreou Savanna,Papacharalambous Revekka,Gerasimou Petroula,Costeas Paul,Angeli Stella,Kousiappa Ioanna,Papacostas Savvas,Kyriakides Theodoros^ORCID

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference48 articles.

1. 2016 Alzheimer’s disease facts and figures;A Alzheimer’s;Alzheimer’s & dementia: the journal of the Alzheimer’s Association,2016

2. Alzheimer’s disease and the amyloid cascade hypothesis: a critical review;C Reitz;International journal of Alzheimer’s disease,2012

3. Abeta-induced inflammatory processes in microglia cells of APP23 transgenic mice;KD Bornemann;The American journal of pathology,2001

4. Differential effects of oligomeric and fibrillar amyloid-beta 1–42 on astrocyte-mediated inflammation;JA White;Neurobiology of disease,2005

5. Microglia in the adult brain arise from Ly-6ChiCCR2+ monocytes only under defined host conditions;A Mildner;Nature neuroscience,2007

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutic Targets in Innate Immunity to Tackle Alzheimer’s Disease;Cells;2024-08-26

2. Beneficial versus Detrimental Effects of Complement–Microglial Interactions in Alzheimer’s Disease;Brain Sciences;2024-04-26

3. The complement system in neurodegenerative diseases;Clinical Science;2024-03

4. Factor H’s Control of Complement Activation Emerges as a Significant and Promising Therapeutic Target for Alzheimer’s Disease Treatment;International Journal of Molecular Sciences;2024-02-14

5. Immune receptors and aging brain;Bioscience Reports;2024-02